Glioblastoma is a dangerous brain cancer known for its rapid growth and resistance to standard treatments. Investigations are constantly underway to identify new management strategies, and recently, a unique biomarker https://delilahijel016218.mpeblog.com/61759320/lca168-for-glioblastoma